ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998

NCI Nears Confrontation Over Construction As OMB Continues Obstructionist Policies

July 11, 1975

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

NCAB Okays Concepts For ICI Contract Support, Databases

October 11, 1991

Einhorn Begins Term; Salmon, Blum Honored; Gore Gives Award To IntraMall, Piloted At NCI.

May 26, 2000